AtriCure Quick Ratio 2010-2025 | ATRC
Historical quick ratio values for AtriCure (ATRC) over the last 10 years.
| AtriCure Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-06-30 | $0.20B | $0.07B | 2.83 |
| 2025-03-31 | $0.18B | $0.06B | 2.88 |
| 2024-12-31 | $0.19B | $0.07B | 2.62 |
| 2024-09-30 | $0.19B | $0.07B | 2.59 |
| 2024-06-30 | $0.18B | $0.06B | 2.93 |
| 2024-03-31 | $0.17B | $0.06B | 2.83 |
| 2023-12-31 | $0.20B | $0.08B | 2.66 |
| 2023-09-30 | $0.19B | $0.08B | 2.31 |
| 2023-06-30 | $0.18B | $0.07B | 2.56 |
| 2023-03-31 | $0.19B | $0.06B | 3.03 |
| 2022-12-31 | $0.17B | $0.06B | 2.90 |
| 2022-09-30 | $0.17B | $0.06B | 2.92 |
| 2022-06-30 | $0.17B | $0.06B | 2.93 |
| 2022-03-31 | $0.16B | $0.05B | 3.35 |
| 2021-12-31 | $0.16B | $0.06B | 2.78 |
| 2021-09-30 | $0.16B | $0.05B | 2.91 |
| 2021-06-30 | $0.20B | $0.07B | 2.94 |
| 2021-03-31 | $0.26B | $0.06B | 4.48 |
| 2020-12-31 | $0.27B | $0.05B | 5.53 |
| 2020-09-30 | $0.26B | $0.05B | 5.85 |
| 2020-06-30 | $0.26B | $0.04B | 6.81 |
| 2020-03-31 | $0.10B | $0.04B | 2.43 |
| 2019-12-31 | $0.11B | $0.05B | 2.28 |
| 2019-09-30 | $0.11B | $0.04B | 2.49 |
| 2019-06-30 | $0.12B | $0.04B | 3.10 |
| 2019-03-31 | $0.13B | $0.04B | 3.69 |
| 2018-12-31 | $0.15B | $0.04B | 3.78 |
| 2018-09-30 | $0.07B | $0.03B | 1.96 |
| 2018-06-30 | $0.07B | $0.03B | 2.37 |
| 2018-03-31 | $0.06B | $0.03B | 2.32 |
| 2017-12-31 | $0.06B | $0.03B | 1.88 |
| 2017-09-30 | $0.06B | $0.04B | 1.65 |
| 2017-06-30 | $0.06B | $0.03B | 1.93 |
| 2017-03-31 | $0.06B | $0.03B | 2.12 |
| 2016-12-31 | $0.07B | $0.03B | 2.36 |
| 2016-09-30 | $0.07B | $0.03B | 2.47 |
| 2016-06-30 | $0.07B | $0.03B | 2.67 |
| 2016-03-31 | $0.05B | $0.03B | 1.77 |
| 2015-12-31 | $0.06B | $0.03B | 1.81 |
| 2015-09-30 | $0.07B | $0.04B | 1.73 |
| 2015-06-30 | $0.08B | $0.03B | 2.48 |
| 2015-03-31 | $0.08B | $0.03B | 3.18 |
| 2014-12-31 | $0.08B | $0.03B | 3.09 |
| 2014-09-30 | $0.08B | $0.02B | 3.48 |
| 2014-06-30 | $0.08B | $0.02B | 4.75 |
| 2014-03-31 | $0.10B | $0.02B | 6.01 |
| 2013-12-31 | $0.04B | $0.03B | 1.58 |
| 2013-09-30 | $0.04B | $0.02B | 2.55 |
| 2013-06-30 | $0.05B | $0.01B | 3.54 |
| 2013-03-31 | $0.05B | $0.01B | 3.83 |
| 2012-12-31 | $0.02B | $0.01B | 1.87 |
| 2012-09-30 | $0.02B | $0.01B | 2.00 |
| 2012-06-30 | $0.03B | $0.01B | 2.12 |
| 2012-03-31 | $0.03B | $0.01B | 2.21 |
| 2011-12-31 | $0.03B | $0.01B | 2.28 |
| 2011-09-30 | $0.03B | $0.01B | 2.53 |
| 2011-06-30 | $0.03B | $0.01B | 2.55 |
| 2011-03-31 | $0.03B | $0.01B | 2.42 |
| 2010-12-31 | $0.03B | $0.01B | 1.92 |
| 2010-09-30 | $0.03B | $0.02B | 1.63 |
| 2010-06-30 | $0.03B | $0.01B | 1.79 |
| 2010-03-31 | $0.02B | $0.01B | 2.06 |
| 2009-12-31 | $0.03B | $0.01B | 2.24 |
| 2009-09-30 | $0.03B | $0.01B | 2.26 |
| 2009-06-30 | $0.03B | $0.01B | 2.73 |
| 2009-03-31 | $0.02B | $0.01B | 3.15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.815B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.878B | 26.72 |
| Boston Scientific (BSX) | United States | $152.546B | 36.38 |
| Stryker (SYK) | United States | $143.342B | 29.18 |
| EssilorLuxottica (ESLOY) | France | $134.414B | 0.00 |
| Medtronic (MDT) | Ireland | $114.542B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.355B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.554B | 23.72 |
| ResMed (RMD) | United States | $41.123B | 29.37 |
| Agilent Technologies (A) | United States | $32.165B | 20.97 |
| GE HealthCare Technologies (GEHC) | United States | $31.941B | 15.01 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $25.229B | 16.69 |
| Insulet (PODD) | United States | $19.515B | 76.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.034B | 11.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.548B | 0.00 |
| Baxter (BAX) | United States | $11.546B | 8.93 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.193B | 26.27 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.640B | 16.58 |
| Lantheus Holdings (LNTH) | United States | $3.589B | 9.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.275B | 22.92 |
| Perrigo (PRGO) | Ireland | $3.246B | 8.11 |
| ICU Medical (ICUI) | United States | $3.123B | 23.03 |
| LeMaitre Vascular (LMAT) | United States | $2.106B | 45.26 |
| QuidelOrtho (QDEL) | United States | $1.585B | 10.02 |
| Green Thumb Industries (GTBIF) | United States | $1.454B | 62.46 |
| AdaptHealth (AHCO) | United States | $1.329B | 18.94 |
| Acuren (TIC) | United States | $1.217B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.126B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.074B | 13.73 |
| Neogen (NEOG) | United States | $1.036B | 16.45 |
| BioLife Solutions (BLFS) | United States | $1.009B | 0.00 |
| InMode (INMD) | Israel | $0.884B | 8.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.743B | 0.00 |
| Valneva SE (VALN) | France | $0.697B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.621B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.46 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.497B | 4.12 |
| CeriBell (CBLL) | United States | $0.462B | 0.00 |
| SNDL (SNDL) | Canada | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.412B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.354B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.290B | 10.67 |
| Quanterix (QTRX) | United States | $0.280B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.255B | 18.97 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Sanara MedTech (SMTI) | United States | $0.218B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.211B | 6.33 |
| Exagen (XGN) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.194B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.150B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.27 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.75 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Veru (VERU) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 12.60 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 42.86 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |